What Additional Factors Beyond State-of-the-Art Analytical Methods Are Needed for Optimal Generation and Interpretation of Biomonitoring Data?

Background The routine use of biomonitoring (i.e., measurement of environmental chemicals, their metabolites, or specific reaction products in human biological specimens) to assess internal exposure (i.e., body burden) has gained importance in exposure assessment. Objectives Selection and validation of biomarkers of exposure are critical factors in interpreting biomonitoring data. Moreover, the strong relation between quality of the analytical methods used for biomonitoring and quality of the resulting data is well understood. However, the relevance of collecting, storing, processing, and transporting the samples to the laboratory to the overall biomonitoring process has received limited attention, especially for organic chemicals. Discussion We present examples to illustrate potential sources of unintended contamination of the biological specimen during collection or processing procedures. The examples also highlight the importance of ensuring that the biological specimen analyzed both represents the sample collected for biomonitoring purposes and reflects the exposure of interest. Conclusions Besides using high-quality analytical methods and good laboratory practices for biomonitoring, evaluation of the collection and handling of biological samples should be emphasized, because these procedures can affect the samples integrity and representativeness. Biomonitoring programs would be strengthened with the inclusion of field blanks.

[1]  Holger M Koch,et al.  Internal exposure of the general population to DEHP and other phthalates--determination of secondary and primary phthalate monoester metabolites in urine. , 2003, Environmental research.

[2]  Bruce D Hammock,et al.  Occurrence of endocrine-disrupting chemicals in indoor dust. , 2008, The Science of the total environment.

[3]  A. Calafat,et al.  Phthalates Biomarker Identification and Exposure Estimates in a Population of Pregnant Women , 2009, Human and ecological risk assessment : HERA.

[4]  Ellen J Lee,et al.  Urine-sampling methods for environmental chemicals in infants and young children , 2009, Journal of Exposure Science and Environmental Epidemiology.

[5]  Dana B Barr,et al.  Uses of speciation techniques in biomonitoring for assessing human exposure to organic environmental chemicals , 2005, Analytical and bioanalytical chemistry.

[6]  Holger M. Koch,et al.  New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP , 2005, Archives of Toxicology.

[7]  Ipcs,et al.  Human exposure assessment , 2000 .

[8]  Ruthann A Rudel,et al.  Endocrine disrupting chemicals in indoor and outdoor air. , 2009, Atmospheric environment.

[9]  A. Calafat,et al.  Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. , 2004, Environmental health perspectives.

[10]  John Keenan Taylor Quality Assurance of Chemical Measurements , 1981 .

[11]  Dennis R. Peterson,et al.  The environmental fate of phthalate esters: A literature review , 1997 .

[12]  Hermann Fromme,et al.  Perfluorinated compounds--exposure assessment for the general population in Western countries. , 2009, International journal of hygiene and environmental health.

[13]  D. Barr,et al.  Pesticide Concentrations in Matrices Collected in the Perinatal Period in a Population of Pregnant Women and Newborns in New Jersey, USA , 2009 .

[14]  J. Angerer,et al.  Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure-- an update and latest results. , 2006, International journal of andrology.

[15]  L. Needham,et al.  Determining volatile organic compounds in human blood from a large sample population by using purge and trap gas chromatography/mass spectrometry. , 1992, Analytical chemistry.

[16]  undefined Fda,et al.  Safety assessment of Di-(2-ethylhexyl) phthalate (DEHP) released from PVC medical devices , 2001 .

[17]  M. Pembrey,et al.  ALSPAC--the Avon Longitudinal Study of Parents and Children. I. Study methodology. , 2001, Paediatric and perinatal epidemiology.

[18]  J. Arnaud,et al.  Sampling conditions for biological fluids for trace elements monitoring in hospital patients: a critical approach. , 1993, Critical reviews in clinical laboratory sciences.

[19]  Antonia M. Calafat,et al.  Exposure to Bisphenol A and Other Phenols in Neonatal Intensive Care Unit Premature Infants , 2008, Environmental health perspectives.

[20]  R. H. Mckee,et al.  Esters of Aromatic Mono‐, Di‐, and Tricarboxylic Acids, Aromatic Diacids and Di‐, Tri‐, Or Polyalcohols , 2001 .

[21]  A. Calafat,et al.  Factors affecting the evaluation of biomonitoring data for human exposure assessment. , 2008, International journal of andrology.

[22]  Dana B Barr,et al.  Uses and issues of biomonitoring. , 2007, International journal of hygiene and environmental health.

[23]  J. Angerer,et al.  Human biomonitoring: state of the art. , 2007, International journal of hygiene and environmental health.

[24]  M. Shelby NTP-CERHR monograph on the potential human reproductive and developmental effects of bisphenol A. , 2008, NTP CERHR MON.

[25]  Charles J. Weschler,et al.  Changes in indoor pollutants since the 1950s , 2009 .

[26]  L. Di,et al.  In vitro solubility assays in drug discovery. , 2008, Current drug metabolism.

[27]  P. Albro,et al.  Toxic potential of the plasticizer Di(2-ethylhexyl) phthalate in the context of its disposition and metabolism in primates and man. , 1982, Environmental health perspectives.

[28]  J. Chuang,et al.  Aggregate exposures of nine preschool children to persistent organic pollutants at day care and at home , 2003, Journal of Exposure Analysis and Environmental Epidemiology.

[29]  A. Calafat,et al.  Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers. , 2003, Environmental health perspectives.

[30]  J. Angerer,et al.  Di(2-ethylhexyl)phthalate (DEHP) exposure of voluntary plasma and platelet donors. , 2005, International journal of hygiene and environmental health.

[31]  S. Caudill,et al.  Multi‐rule quality control for the age‐related eye disease study , 2008, Statistics in medicine.

[32]  이수정 해외산업간호정보 - 미국 산업안전보건연구원(National Institute for Occupational Safety and Health) 소개 , 2009 .

[33]  Hermann Fromme,et al.  Determination of free and total bisphenol A in human urine to assess daily uptake as a basis for a valid risk assessment. , 2008, Toxicology letters.

[34]  A. Calafat,et al.  Measurement of eight urinary metabolites of di(2-ethylhexyl) phthalate as biomarkers for human exposure assessment , 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[35]  Ken Sexton,et al.  Human Biomonitoring of Environmental Chemicals , 2004 .

[36]  Hiroyasu Ito,et al.  Microbial Production and Vaporization of Mono-(2-ethylhexyl) Phthalate From di-(2-ethylhexyl) Phthalate by Microorganisms Inside Houses , 2005, Archives of environmental & occupational health.

[37]  A. Calafat,et al.  Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit. , 2004, Pediatrics.

[38]  L. Barregard,et al.  People with high mercury uptake from their own dental amalgam fillings. , 1995, Occupational and environmental medicine.

[39]  Holger M. Koch,et al.  Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP , 2004, Archives of Toxicology.

[40]  H. Dirven,et al.  Determination of four metabolites of the plasticizer di (2-ethylhexyl) phthalate in human urine samples , 1993, International archives of occupational and environmental health.

[41]  R. Ulvik,et al.  Evaluation of methods for trace‐element determination with emphasis on their usability in the clinical routine laboratory , 2007, Scandinavian journal of clinical and laboratory investigation.